Efficacy of traditional Chinese medicine combined with acupuncture (pressing acupuncture) in the treatment of COVID 19

Phase 1

Recruiting

• Conditions: ovel Coronavirus Pneumonia (COVID-19)

• Registration Number: ITMCTR2200005876
• Lead Sponsor: The Affiliated Hospital to Changchun University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic criteria for patients with Covid 19 in the Covid 19 Pneumonia Diagnosis and Treatment Program (Trial Version 9);
2. The clinical classification is mild and common;
3. The patient's aged >= 18 years.

Exclusion Criteria

1. Patients who have used similar proprietary Chinese medicines before enrollment;
2. Patients with immunodeficiency diseases or used immunosuppressive agents or glucocorticoids within the past 3 months;
3. Women preparing for pregnancy, pregnant and lactating women;
4. Allergic constitution patients (referring to those allergic to two or more drugs or foods or to the known ingredients of the drug in this trial);
5. Mental patients, or patients without self-awareness. 5. Not suitable to participate in clinical trials judged by the investigator;
6. Patients not suitable to participate in the clinical trial.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical symptoms cure rate;

Secondary Outcome Measures

Name	Time	Method
Severe symptom conversion rate;Fever reduction time;The disappearance time and rate of single symptom;Haspitalization time;Clinical symptoms recovery time;COVID 19 negative time;